Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis

Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis

Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the course of these debilitating diseases. Medical management of symptoms for both diseases leverages combined hormonal contraceptives used off label...

Full description

Bibliographic Details
Main Authors: Juan C. Arjona Ferreira, M.D., Elizabeth Migoya, Pharm.D.
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:F&S Reports
Subjects:
relugolix
GnRH antagonist
add-back therapy
uterine fibroids
endometriosis
bone mineral density loss
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334122001210

Internet

http://www.sciencedirect.com/science/article/pii/S2666334122001210

Similar Items